#United States #Grand Rapids #Jim Alecxih #Virtual Incision #MIRA Surgical System

Virtual Incision Appoints Jim Alecxih as CEO

On June 24, 2025, cultivate(MD), a preeminent medical device venture capital firm, announced a significant development for its portfolio subsidiary, Virtual Incision Corporation. The company has appointed Jim Alecxih as its new Chief Executive Officer. Alecxih brings over three decades of experience in the medical device industry, notably during his impactful tenure at Intuitive Surgical, where he contributed to the widespread adoption of the da Vinci Surgical System.

A New Chapter for Virtual Incision

This strategic appointment comes at a critical juncture for Virtual Incision, as the company is set to accelerate the development and commercialization of its next-generation robotic surgical system, the M2. This innovative system represents a revolutionary step in robotic-assisted surgery, being designed to be miniaturized, simple, yet highly effective. Alecxih expressed his excitement about leading Virtual Incision, highlighting the importance of robotic-assisted surgery in enhancing patient care and accessibility, particularly in rural and underserved healthcare facilities.

Vision for the Future

Jim Alecxih's leadership will focus on expediting the development of the M2 system, which is anticipated to minimize costs and streamline the surgery process. Unlike traditional mainframe cart-based systems, M2 is designed as a compact, single-port robotic surgical system, potentially transforming how surgeries are conducted across diverse medical environments. Its design allows for significantly improved surgical efficiency, easing logistical challenges associated with conventional systems.

Alecxih's vision is to ensure that robotic-assisted surgery becomes accessible not just to major hospitals but rural healthcare providers as well. He emphasized that M2's design and capabilities aim to democratize surgical technology, enabling a broader reach for robotic-assisted procedures worldwide.

Accomplishing Milestones in Innovation

Under Alecxih's guidance, Virtual Incision is also set to enhance its innovation track record. The company has recently garnered recognition as a finalist in prestigious accolades including the Fast Company’s “World’s Most Innovative Companies,” SXSW Innovation Award, and Fierce MedTech’s “Fierce 15” in 2025. These honors reflect the company’s commitment to pioneering advancements in surgical technology and the significant potential of its MIRA Surgical System, which is recognized for its design and operational efficacy.

The MIRA Surgical System

The MIRA Surgical System is notable for being the first miniature robotic-assisted surgery system designed to perform procedures like colectomies with high precision. Weighing approximately two pounds, MIRA can be rapidly deployed in any operational setting, eliminating the need for dedicated surgical rooms, which is a significant limitation of existing robotic technologies.

MIRA's easy setup, minimalistic cleaning process, and portability make it a versatile tool that can be used for a variety of surgical applications, either as a standalone system or alongside existing surgical robotic systems. It offers hospitals and surgical facilities a chance to enhance their surgical suite without the major capital investments typically associated with larger robotic systems.

Commitment to Healthcare Innovation

The appointment of Jim Alecxih as CEO aligns perfectly with cultivate(MD)'s mission to foster medical innovation and support groundbreaking healthcare solutions. By focusing on developing cost-effective and accessible surgical technologies, Virtual Incision aims to redefine the landscape of robotic-assisted operations, enabling more patients to benefit from advanced surgical options.

As the world of healthcare continues to evolve, the partnership between cultivate(MD) and Virtual Incision thrives under Alecxih's leadership, promising to bring transformative solutions to surgical practices globally. The future of robotic-assisted surgery is bright, and with M2 on the horizon, Virtual Incision is poised to make its mark in this rapidly advancing field.